NutriventiaProductPortfolio
NutriventiaProductPortfolio
NutriventiaProductPortfolio
nutriventia.com I info@nutriventia.com
nvtriventia.
compliant
Award winning ingredient
Learn more >
3 PK
STUDIES 3 CLINICAL STUDIES
(J O I N T, D O M S, OA) 1 M E TA - A N A LY S I S A N D
SY S T E M AT I C R E V I E W
Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,
treat cure, or prevent any disease.
TurmXTRA™ mark is a registered trademark of Nutriventia Limited.
A complete clinical package
3 P H A R M AC O K I N E T I C S T U DY
S T U DY 1 A N D S T U DY 2 –
90 60
TurmXTRA™60N TurmXTRA™60N
80
50
Std 95%TE Std 95%TE
70
curcuminoids (ng/mL)
curcuminoids (ng/mL)
60 40
50
30
40
30 20
20
10
10
0 0
0 4 8 12 16 20 24 0 4 8 12 16 20 24
Time (h) Time (h)
Source: Thanawala S, Shah R, Alluri KV, Somepalli V, Vaze S, Upadhyay V. Comparative bioavailability of curcuminoids
from a water-dispersible high curcuminoid turmeric extract against a generic turmeric extract: a randomized, cross-over,
comparative, pharmacokinetic study. J Pharm Pharmacol. 2021 Apr 27;73(6):816-823. doi: 10.1093/jpp/rgab028.
PMID: 33755149.
S T U DY 3 -
Pharmacokinetic study 3
70 TurmXTRA™60N
Mean plasma concentration of total
60 Branded TE+
5mg piperine
curcuminoids (ng/mL)
50
40
30
20
10
0
0 5 6 10 12 15 20
Source: Thanawala S, Shah R, Doyle L, Upadhyay V. Comparative pharmacokinetics of curcuminoids from water
dispersible turmeric extract against a curcuminoids-piperine combination : An open label, randomized, balanced,
2-Treatment, 2-Sequence, 2-Period Crossover Study. Alt Ther. 2024 Apr; 30 (4) : 18-23
Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,
treat cure, or prevent any disease.
TurmXTRA™ mark is a registered trademark of Nutriventia Limited.
S T U DY 4 - J O I N T H E A LT H S T U DY
Time (s)
Time (s)
VAS
S T U DY 5 - D E L AY E D O N S E T M U S C L E S O R E N E S S (D O M S) S T U DY
Time (hr)
VAS
Source: Thanawala S, Shah R, Karlapudi V, Desomayanandam P, Bhuvanendran A. Efficacy and Safety of TurmXTRA® 60N in Delayed Onset Muscle
Soreness in Healthy, Recreationally Active Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Evid Based Complement Alternat TurmXTRA™60N Placebo
Med. 2022 Aug 5;2022:9110414. doi: 10.1155/2022/9110414. PMID: 35966736; PMCID: PMC9374544.
Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,
treat cure, or prevent any disease.
TurmXTRA™ mark is a registered trademark of Nutriventia Limited
S T U DY 6 - O S T E OA R T H R I T I S S T U DY
Our randomized, double-blind, placebo controlled, parallel group 90-day study on 139
subjects with mild to moderate knee osteoarthritis proved the efficacy and safety of
TurmXTRA™60N in significantly reducing pain and improving comfort & knee function.
Manuscript under publication
Visual analog scale (100 mm) Knee Injury and Osteoarthritis Outcome score
Better Comfort (VAS) Reduced Pain (KOOS) Better Knee Function
2.4 times improvement Nearly 4x times improvement 2.3 times improvement
Change in pain (VAS) as Change in pain (KOOS) Change in knee related quality of
compared to placebo as compared to placebo life as compared to placebo
TurmXTRA™60N Placebo
H E A LT H B E N E F I T S
Immune Liver
health health
L I C E N S E S & C E R T I F I C AT I O N S
nutriventia.com | info@nutriventia.com
TM
Learn more >
USP compliant
3
A comprehensive clinical package
Mean plasma concentration of total
2.5
withanolidies (ng/mL)
P H A R M A C O K I N E T I C S T U DY *
2
Compared to a leading branded Ashwagandha ingredient,
ProlanzaTM showed -
1.5
Extended Availability 0
Withanolides from ProlanzaTM are available in plasma for upto 0 2 4 6 8 10 12 14 16 18 20 22 24
**
* S T U DY 3 – M U LT I A R M - S T R E S S S T U DY
Randomized, double-blind, placebo-controlled, 60 days, multi arm study on
126 mild to moderate stressed.
Timed release,
melatonin
Melotime™ is a patent-pending and
proprietary extended-release melatonin
ingredient that helps mimic the body’s
natural sleep pattern and supports
quality sleep. The unique release profile
of Melotime™ ensures a release of a
significant portion in the first hour followed
by continuous release of melatonin upto
6 hours for maintenance. This ensures a
quick on-set and maintains good quality
of sleep.
MARKET INSIGHTS
PR AC T I CA L A PPL I CAT I O N S
Gummies
Tablets Melotime showed upto 50% release in
& chews
1st hour, with periodic release in a
6-hour interval for uninterrupted sleep
Stick packs
Capsules
(powder)
Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,
treat, cure or prevent any disease.
Melotime ™ is a trademark of Nutriventia Limited.
S U S TA I N E D RE L E A S E PRO FI L E
PH A R M AC O K I N E T I C S T U DY
18000
Mean plasma concentration of
16000
14000
melatonin (pg/mL)
12000 Faster
elimination
10000
8000
6000
4000 Disturbed sleep
Slower Sound sleep
2000 elimination
0
0 1 2 3 4 5 6 7 8
Time (h)
Melotime Melatonin IR
H E A LT H B E N E F I T S
Cognitive Immune
health health
L I C E N S E S & C E R T I F I C AT I O N S
nutriventia.com | info@nutriventia.com
Distributed in the USA by Aviva Natural Supplements
Distributed in Europe by Vivatis Pharma GmbH
12 hour Boost for
focus & alertness
Learn more >
Long-acting caffeine
Caffeine stimulates the nervous system leading
to improved alertness, exemplified motor
coordination, and recharged focus. The most
significant issue with caffeine is that its effects
start to diminish after a couple of hours due
to quick absorption of caffeine within the body.
High and/or multiple doses leads to caffeine
tolerance which could lead to jitteriness,
headache, and nervousness collectively
known as ‘caffeine crash’. CaffXtend™ is a
unique patent product that delivers natural
caffeine for 12 hours, from a natural matrix using
our proprietary modified-release technology.
MARKET INSIGHTS
H E A LT H B E N E F I T S
Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,
treat, cure, or prevent any disease.
CaffXtend™ mark is a registered trademark of Nutriventia Limited.
S U S TA I N E D R E L E A S E P R O F I L E
Clinically substantiated to reduce perception
of ‘tiredness’ for an extended duration (12
hours) from a single dose
P H A R M AC O K I N E T I C S T U DY
1. Extended action through sustained 3. Significantly lower scores
release profile of CaffXtend™ for ‘tired’ and ‘jittery’
Extended Tmax – 391.57% Lesser perception of tiredness and jitters
(to reach maximum concentration)
4. Lower scores for parameters
Extended half-life T½ – 22.32% longer
indicative of ‘caffeine crash’
2. Extended efficacy through sustained No caffeine crash, hence safer
release profile of CaffXtend™ from a
Caff-VAS (Caffeine Research Visual 5. CaffXtend™ is beneficial with better
Analog Scales)** significantly higher efficacy, as compared to repeated
scores for ‘overall mood’, ‘relaxed’ caffeine dosing
and ‘alert’
Substantiated from data of human clinical trial
Better mood & more alertness compared with equal dose of natural caffeine
clin
spike
e
4000 Gradual
decline
diate
3500
3000
Imme
e e
as iv
2500
re ess
2000
inc ogr
Pr
1500
1000
500
0
0 2 4 6 8 10 12
Time (hrs.) Caffeine IR
L I C E N S E S & C E R T I F I C AT I O N S
nutriventia.com | info@nutriventia.com
Shields you for 24 hour
Vitamin C protection
Learn more >
MARKET INSIGHTS
H E A LT H B E N E F I T S
C-fence™ has shown 12-hr sustained
release Vitamin C in-vitro.
Tablets
Any of these statements have not been evaluated by the Food and Drug Administration. This ingredient is not intended to diagnose,
treat, cure, or prevent any disease.
C-Fence™ mark is a registered trademark of Nutriventia Limited.
IN VITRO DISSOLUTION
PHARMOKINETIC
1200 85x
Extended
Avg. concentration of Vit. C (ng/ml)
Tmax
1000
800
Cmax compared
85x 600
to baseline 0hrs
400 20x
H E A LT H B E N E F I T S
Brain Skin
Antioxidant
health health
Immune Cardiovascular
health health
L I C E N S E S & C E R T I F I C AT I O N S